⚕️ Full Prescribing Information

For complete safety information, warnings, and dosage guidelines:

View FDA Label (PDF) →

📋 Overview

Trulicity (dulaglutide) is a once-weekly injectable GLP-1 receptor agonist for type 2 diabetes. It helps lower blood sugar and has cardiovascular benefits.

How It Works

Trulicity mimics the GLP-1 hormone, stimulating insulin release when blood sugar is high, slowing gastric emptying, and reducing glucagon secretion.

✓ FDA Approved Uses

  • Improve blood sugar in type 2 diabetes
  • Reduce cardiovascular risk in adults with type 2 diabetes
  • May promote weight loss

🧪 Required Lab Monitoring

Your healthcare provider will order these tests to monitor your treatment:

Hemoglobin A1C Test
Every 3 months until stable, then every 6 months
Kidney Function Test
Baseline and annually
Lipid Panel (Cholesterol Test)
Baseline and annually

Need to book these tests?

Order Tests Online →

⚡ Common Side Effects

Contact your doctor if these persist or worsen:

  • Nausea
  • Diarrhea
  • Vomiting
  • Abdominal pain
  • Decreased appetite
  • Fatigue

🚨 Serious Side Effects

Seek immediate medical attention if you experience:

  • Pancreatitis
  • Thyroid tumors (box warning)
  • Severe gastrointestinal disease
  • Acute kidney injury
  • Severe allergic reactions

⚠️ Do Not Use If

  • Personal or family history of medullary thyroid carcinoma
  • Multiple endocrine neoplasia syndrome type 2
  • History of pancreatitis
  • Severe gastrointestinal disease

📢 Important Warnings

  • Boxed warning: Risk of thyroid tumors
  • Stop immediately if pancreatitis suspected
  • Not for type 1 diabetes
  • Monitor kidney function

📚 Sources

Last Reviewed: April 2026